Stroke, Neurology and Cerebrovascular Diseases

Chairman & CEO at Alzheimers Disease International, London, United Kingdom Studied M.B.B.S at University of Mysore Past: st.marys high school,thalacode Lives in Trichur, Kerala, India

Alzheimers and related diseases

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Stroke, Psychiatry and Psychology

Neuroscience Research NEUROHEALTH NEUROCIENCIAS Aplicadas (NEURONA) at Neurohealth Neurociencias Aplicadas, Senior management - Founder and researcher Neuroscientist at Fundacion Neurona and rotating internship - applied researcher at UNCIP Unidad de Neurocirugía Pediátrica

Neuroscience, Neurology

Graduated in Medicin from Universidade Federal de Santa Catarina (1988), medical residence in internal medicine and clinical neurology (1989-93); masters in internal medicine by Universidade Federal do Paraná (2003); PhD by Universidade de São Paulo (2008); Post- Doctoral by University of Edinburgh, UK (2011). Has experience in Neurology, Collective Health, focusing on Epidemiology, acting on the following subjects: stroke epidemiology, primary and secondary prevention of atherosclerosis, biobank and stroke units. Professor of Neurology and pos-graduation program at University of Joinville, Brazil. Coordinator of Joinville Stroke

Clinical Neurology, Internal medicine

Neurologist and board certified Neurointensivist, currently pursuing further training in Endovascular Surgical Neuroradiology. My research expertise is in the pathophysiology of subarachnoid hemorrhage and especially in cerebral vasospasm as well as acute ischemic stroke. My goal is to synergize my clinical training and research skills; to gain in depth understanding of subarachnoid hemorrhage and ischemic stroke and to better treat various other devastating neurological diseases. I strive to improve patient outcomes by early identification of novel treatment targets and enable innovations in precision medicine.

Neuroradiology, Neurosurgery

Dr. Suhail Rasool has expertise in evaluation and passion in identifying therapeutic modalities for various Neurodegenerative diseases including Alzheimer’s disease. In the last 6 years Dr. Suhail has published more than 20 papers in peer reviewed and high impact factor journals. I have put forth significant contributions to my field. I have screened various conformation antibodies and I also have studied the effects of various antibodies and antigens for treatment of Alzheimer’s disease. I studied the various transgenic mouse mice models and Alzheimer’s disease human brains by utilizing various conformational antibodies and antigens

Alzheimer’s disease, Neurodegenerative diseases

Research Associate at CHU Sainte-Justine, CEO at Neurotechsr and Postdoctoral Researcher at Montreal Neurological Institute. Studied Sciences neurologiques at Université de Montréal

Neurosceince and Neurology

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Psychiatry, Addictions and Neuropsychiatry , Stroke

Bruno Giometto, MD, is the director of Dept. of Neurology in Padova and was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals. He is Vice-President of the Italian Neurological Society.

NeuroOncology,Neurology

Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR and MEK as potential therapeutic targets in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST.Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004.

Molecular Biology, Cancer Biology and Neural Tumors.

Guido Cavaletti, MD, is a certified neurologist since 1990. He is the Head of the Experimental Neurology Unit at the University of Milano-Bicocca and has a long-lasting experience in the preclinical and clinical assessment of CIPN. He has published more than 200 full papers in peer-reviewed journals, he is is consulted by the FDA, NIH and EMA and has been serving as associate editor of the Journal of the Peripheral Nervous System and as editorial board member of Experimental neurology and Current medicinal Chemistry.

Neurology

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine.

NeuroOncology and Neurosurgery

Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Ammirati Mario is an expert in Neurological Surgery.He has completed fellowship training in Neurosurgical Oncology at The The Ohio State University and has a special interest in primary and metastatic tumors of the brain and spine.

Primary and metastatic tumors of the brain and spine.

Yusuf Al-Bustanji is an assistant professor at United Arab Emirates University. He is a licensed and certified speech language pathologist specializing in Neurogenic Communication Disorders from The Ohio State University. He has over 20 years of experience in providing clinical evidence-based therapy services to individuals diagnosed with communication and swallowing disorders in acute care and rehabilitation centers at hospital settings.

Dr. Qureshi is a Fellow in the Royal College of Physicians and Surgeons of Canada in the specialty of Neurology, a Member of the American Academy of Neurology, and a Member of the Canadian Society of Clinical Neurophysiologists. Graduate Of King Faisal University/ Dammam University Neurology Residency at university of Toronto 2003 Dr. Qureshi is active in many organizations. She is currently the Head of the Scientific Committee and Vice President of the Saudi Stroke Association, a Member of the executive board of the Saudi Neurology Society, a Member of the editorial board of the Saudi Medical Journal, and Ex-Head of the Islamic League for Sciences in the Eastern Province of Saudi Arabia. Member of Executive Board Of Saudi Epilepsy Society and Saudi chapter of epilepsy in past Member of faculty of 1000 at international league against epilepsy . Helped in organization and Program review of many SAGA and SSA scientific activities. Public awareness programs mainly in Eastern province almost every year .Promotion of stroke through multitudes of lectures at academic centers, community and along with teaching courses. Established stroke pathway. Established adopted orders for thrombolysis, acute stroke care and transfer of stroke patient with our institute

Neurosurgery, Acute Stroke therapies and thrombolysis

Dr Bohlega obtained his basic medical training at King Saud University and graduated in 1980. Then in 1982, he went to Canada where he underwent his training in Neurology at the University of British Columbia, Vancouver BC. He developed specialist interest in Multiple Sclerosis, Movement Disorders and did subspecialty training in Neurophysiology. In 1989, he joined the Department of Neurosciences at King Faisal Specialist Hospital and Research Centre and worked as a ConsultantNeurologist and then was promoted as a Senior Consultant and later was appointed as Professor of Neurology at Al Faisal University.He is a member of many prestigious neurological societies like the American Neurological Association (ANA) and the British Royal College of Physicians and Surgeons. He worked as a Section Head of Neurology then as Chairman of Department of Neurosciences. Also, he is the founder and a chairperson of the National Saudi Board of Neurology for ten years. He is the Chairman of Saudi Multiple Sclerosis Advisory Group. Currently, he is the President of the Saudi Neurology Society (SNS) and the current President of the PAN Arab Union of Neurological Societies (PAUNS). He received numerous national and international awards for his clinical and academic contributions. To date, Dr Bohlega has published more than 140 papers in a peer reviewed journal. He wrote a few book chapters. He also presented more than 200 presentations in various conferences.

He is a professor of Neurology and the Dean of the Medical Faculty at the University of Dresden, Germany. As well as being a member of numerous scientific societies, including The Movement Disorder Society, the European Neurological Society and the American Academy of Neurology. Professor Reichmann is past-President of the European Neurological Society and was the former President of the German Parkinson Society and President of the German Neurological Society. He currently serves on the editorial boards of the Journal of Neurology, European Journal of Neurology, the Journal of Neural Transmission, Journal of Parkinsonism and Related Disorders, Acta Myologica and Aktuelle Neurologie. Professor Reichmann’s research involves biochemical and genetic analyses of energy metabolism, especially in neurodegenerative disorders and mitochondrial cytopathies. He is highly involved in animal models mimicking Parkinson’s disease and works on premotor signs in PD. He has published more than 300 papers in peer-reviewed journals.

Derk W. Krieger MD PhD has spent his entire carrier in academic neuroscience. After Medical School in Germany he did a neurology residency in Aachen and Heidelberg, Germany. He conducted clinical research in the field of neurophysiology and obtained a PhD in Neurology. He also obtained training in Neurocritical Care with special board’s recognition. In 1996 he accepted a position as director of neurological critical care at the University of Texas at Houston, USA and moved to the Cleveland Clinic Foundation as a stroke consultant and researcher in 1998. He obtained training in Endovascular Therapeutics in 2000-2004. In 2007 he accepted a position as Clinical Professor for Cerebrovascular Diseases at the University of Copenhagen, Denmark along with a consulting position at the Universities teaching hospitals. He has conducted numerous clinical trials and has served as a consultant for pharmaceutical & medical device companies as well as government agencies. In his new position he is involved with the creation of a comprehensive stroke center for the city of Copenhagen, research with particular emphasis on clinical therapeutic trials, along with teaching medical students, residents and fellows at the University and teaching hospitals.

He is professor and head of the department of neurology at the Janakpuri Super Speciality Hospital. He was elected president of Indian Academy of Neurology (IAN). He assumed the charge as IAN president on October 7 during the 20th Annual Conference of Indian Academy of Neurology (IANCON 2012) ,In 2012, he was unanimously elected president of Asian Oceanian Association of Neurology (AOAN) for a period of four years (2012-16) at the 13th Asian Oceanian Congress of Neurology (AOCN) and Australian and New Zealand Association of Neurologists held in Melbourne, Australia.

Dr. Kursad Kutluk is Professor of Neurology at Dokuz Eylul University in Izmir. After completing his residency training at Hacettepe University in Ankara, he worked as a visiting clinician at Neuroradiological Department in University of Freiburg, Germany. He was the Head of Turkish Stroke Society He was the Co-Chair of 9th World Stroke Congress. Currently, he is the chairman of Neurological Department and Director of Stroke Unit. He is the Coordinator of Turkish Thrombolytic Therapy Study Group.His main clinical and research interests are acute stroke management and secondary prevention.

Dr. Mohammad Amjad Kamal is a Distinguish Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia, where he was full Professor from March 2011 to March 2013, and led a highly productive and collaborative research team. Dr. Kamal\\\'s biochemical research has culminated in more than 200 publications in internationally respected journals, and 64 abstracts at international conferences. His research involves ongoing collaborations with numerous international scientific teams and, as an example among many successful projects, was pivotal in supporting the development of novel experimental drugs to treat Alzheimer\\\'s disease from conception in the laboratory to the clinic with his longtime collaborator Dr Nigel H. Greig.

Member of Scientific Committee of Saudi Board of Endocrinology and Diabetes , Saudi Commission for health specialties SCHS .Treasurer and Board member of Saudi Society of Endocrinology and Metabolism Former Member of Scientific committee and examination committee of Saudi Board of Internal Medicine SCHS for 8 years (two terms). Former Chairman of local training supervising committee for Saudi Board of Medicine for central province SCHS .Former Deputy Chairman for National committee for Diabetes MOH. Former Member of consulting committee for Diabetes in Ministry of Health. Member of many other Scientific and administrative committees. Endocrine hormonal Secretions and Diabetes Management.

Dr. Carmelo Chisari received his MD from the University of Padova (Italy). He did his neurology residency at Pisa University (Italy) where he received his Post-graduate specialization in Neurology. He receivedpostdoctoral training in Neurorehabilitation and Neurophysiologyat the Department of Neuroscience, University of Pisa. From 2003 he isAdjunt Assistant Professor of Neurorehabilitationat the University of Pisa. From 2012 isChiefof the“Laboratory for the study and treatment of motor disorders”at the University Hospital of Pisa. Dr. Chisari’s lab is interested in the mechanisms underlying plastic changes in the human central nervous system and in the development of novel therapeutic approaches for recovery of function based on the understanding of these mechanisms. Referee ad hoc for several International Journals in the field of Neuroscience and Neurorehabilitation.

He is Associate Professor of Neurosurgery, Head, section of Neurological Surgery, Department of surgery, college of medicine, King Abdulaziz University, Jeddah. He is also member of the scientific committee of the Saudi Neurosurgery program for the Saudi Council for Health Specialties.He founded and established Neurosurgery department of surgery at KAU, Jeddah in 1998. Surgery for Brain Tumors, Epilepsy Surgery,Spine Surgery,Pediatric Neurosurgery,Vascular Neurosurgery.

Dr.Kaydar M. Al-Chalabi is a physiatrist working in the Neuro-Spinal Hospital of Dubai, UAE. He is also a Specialist Physician In Physical Medicine ,Rheumatology And Rehabilitation in RMRC(Rheumatology, Rehabilitation Medicine And Physiotherapy Clinic) Dr. Chalabi used to be the CEO & Chairperson of JCI Accreditation Committee at Neuro-Spinal Hospital Dubai (2005 till 2011). In addition, he practiced as consultant physician and a general director of the Iraqi National Spinal Cord Injuries Center (NSCIC), 2003 till 2005. Dr. Chalabi has been actively involved in many national and international conferences both as a key speaker and an attendee.

Dr. Al Hassan, established the first stroke program in Kuwait, with the establishment of a full acute stroke unit a the Amiri Hospital. He\'s main interest is teaching, he serves as a tutor at kuwait university, and he is also the vice program director for the kuwait neurology board.